Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study

References

• Arima H, Motoyama K, Higashi T. (2017). Potential use of cyclodextrins as drug carriers and active pharmaceutical ingredients. Chem Pharm Bull 65:341.
   PubMed Web of Science ®Google Scholar
• Bulani VD, Kothavade PS, Kundaikar HS, et al. (2016). Inclusion complex of ellagic acid with β-cyclodextrin: characterization and in vitro anti-inflammatory evaluation. J Mol Struct 1105:308–15.
   Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. (2016). Cancer statistics in China, 2015. Ca Cancer J Clin 66:115–32.
   PubMed Web of Science ®Google Scholar
• Desantis CE, Fedewa SA, Goding SA, et al. (2016). Breast cancer statistics, 2015: convergence of incidence rates between black and white women. Ca Cancer J Clin 66:31–42.
   PubMed Web of Science ®Google Scholar
• Eid EEM, Abdul AB, Suliman FEO, et al. (2011). Characterization of the inclusion complex of zerumbone with hydroxypropyl-β-cyclodextrin. Carbohyd Polym 83:1707–14.
   Web of Science ®Google Scholar
• Gao W, Zhang J, Yang H, et al. (2011). Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway. Toxicol in Vitro 25:51–63.
   PubMed Web of Science ®Google Scholar
• Hafner V, Czock D, Burhenne J, et al. (2010). Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration. Antimicrob Agents Ch 54:2596.
   PubMed Web of Science ®Google Scholar
• Hu L, Zhang H, Song W, et al. (2012). Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin. Carbohydr Polym 90:1719–24.
   PubMed Web of Science ®Google Scholar
• Kadari A, Gudem S, Kulhari H, et al. (2017). Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles. Drug Deliv 24:224.
   PubMed Web of Science ®Google Scholar
• Kulkarni AD, Belgamwar VS. (2017). Inclusion complex of chrysin with sulfobutyl ether-β-cyclodextrin (Captisol®;): preparation, characterization, molecular modelling and in vitro anticancer activity. J Mol Struct 1128:563–71.
   Web of Science ®Google Scholar
• Li B, Chen S, Shi Z, Chen Y. (2000). Jaridonin, a novel ent-Kaurene diterpenoids from Isodon rubescens, inducing apoptosis via production of reactive oxygen species esophageal cancer cells. Phytochemistry 53:855–9.
   PubMed Web of Science ®Google Scholar
• Liu G, Ding L, Yang Y, et al. (2006). Anti-oxidative action of ent-kaurene diterpenoids. Res Chem Intermed 32:787–94.
   Web of Science ®Google Scholar
• Loh G, Tan Y, Peh K. (2016). Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl-β-cyclodextrin. Asian J Pharm Sci 11:536–46.
   Web of Science ®Google Scholar
• Luke DR, Konrad T, Bharat D, Schlamm HT. (2010). Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD). J Pharm Sci 99:3291–301.
   PubMed Web of Science ®Google Scholar
• Nair AB, Attimarad M, Al-Dhubiab BE, et al. (2014). Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin. Drug Deliv 21:540–7.
   PubMed Web of Science ®Google Scholar
• Pan H, Wang HB, Yu YB, et al. (2017). Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: supercritical fluid process. Acta Pharmaceut 67:85.
   PubMed Web of Science ®Google Scholar
• Ren L, Ma B, Chen G, et al. (2013). Quantitative determination of glaucocalyxin A in rat plasma by LC-MS/MS: application to a preclinical pharmacokinetic study. Anal Methods 5:4890–7.
   Web of Science ®Google Scholar
• Shang X, Ma S, Wu J, Bai S. (2011). Preparation of glaucocalyxin A-hydroxypropy-β-cyclodextrin inclusion complex. Chinese J New Drugs 20:1243–6.
   Google Scholar
• Sivakumar K, Parinamachivayam G, Krishnan MM, et al. (2018). Preparation, characterization and molecular modeling studies of the beta-cyclodextrin inclusion complex with benzoguanamine and its analytical application as chemosensor for the selective sensing of Ce4+. Spectrochim Acta A 200:212–25.
   Web of Science ®Google Scholar
• Tang L, Jin X, Hu X, et al. (2016). Glaucocalyxin A inhibits the growth of liver cancer focus and SMMC-7721 cells. Oncol Lett 11:1173–8.
   PubMed Web of Science ®Google Scholar
• Uchida R, Iwamoto K, Nagayama S, et al. (2015). Effect of γ-cyclodextrin inclusion complex on the absorption of R-α-lipoic acid in rats. Int J Mol Sci 16:10105–20.
   PubMed Web of Science ®Google Scholar
• Wang H, Xie X, Zhang F, et al. (2011). Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives. Food Chem Toxicol 49:1387–93.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li Z, Shi L, et al. (2008). Advances in research on cytotoxinic activity of ent-kaurane diterpenoids. Chinese J Org Chem 28:1911–7.
   Web of Science ®Google Scholar
• Zhang Q, Polyakov NE, Chistyachenko YS, et al. (2018). Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. Drug Deliv 25:198–209.
   PubMed Web of Science ®Google Scholar
• Zhang C, Qu Y, Jia Y, et al. (2015). Preparation and antitumor effects of glaucocalyxin A-γ-cyclodextrin clathrate. Int J Clin Exp Med 8:14388.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sha D, Sha M, Yuan C. (1991). Determination of glaucocalyxin A in the leaves of Plectranthus japonicus (Burm.) Koidz. var. glaucocalyx (Maxim.) Koidz. by HPLC. China J Chinese Materia Medica 16:679.
   Google Scholar
• Zhu J, Sun Y, Lu Y, et al. (2018). Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway. Cell Death Dis 9:708.
   PubMed Web of Science ®Google Scholar